LeMaitre Vascular, Inc. (LMAT) Stock Price

LMATStock

$80.82−6.93%52W

Market Cap$1.85B

P/E32.01x

PEG Ratio2.19

Div yield1.05%

Beta0.50

LMAT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-41.06%

Price vs S&P 500 (4W)3.37%

PEG Ratio2.19

VGM Score51.35

P/E Ratio (Annual)32.01x

Indicated Dividend Yield (Annual)1.05%

P/CF (Annual)22.75x

Book Value / Share (Quarterly)$18.38

P/TBV (Annual)5.10x

Indicated Dividend (Annual)$1.00

Revenue Growth (3Y)15.57%

Cash Flow / Share (Quarterly)$3.23

Payout Ratio (TTM)31.21%

Price vs S&P 500 (YTD)-12.27%

Gross Margin (TTM)72.90%

Net Profit Margin (TTM)25.02%

EPS (TTM)$2.77

10-Day Avg Trading Volume0.27M

EPS Excl Extra (TTM)$2.77

Revenue Growth (5Y)14.04%

EPS (Annual)$2.52

Dividend / Share (Annual)$0.80

ROI (Annual)10.27%

Gross Margin (Annual)71.53%

Net Profit Margin (5Y Avg)17.78%

Cash / Share (Quarterly)$16.45

P/E Basic Excl Extra (TTM)28.14x

Revenue Growth QoQ (YoY)9.57%

EPS Growth (5Y)19.48%

P/E Normalized (Annual)32.01x

ROA (Last FY)9.38%

Revenue Growth TTM (YoY)11.85%

EBITD / Share (TTM)$3.49

ROE (5Y Avg)11.22%

Operating Margin (TTM)29.46%

Cash Flow / Share (Annual)$3.27

P/B Ratio4.40x

P/B Ratio (Quarterly)5.22x

Net Income / Employee (Annual)$89,400

EV / Revenue (TTM)7.59x

Net Interest Coverage (TTM)17.33x

ROA (TTM)10.58%

EPS Growth QoQ (YoY)15.47%

EV / EBITDA (TTM)24.00x

EPS Incl Extra (Annual)$2.52

Current Ratio (Annual)12.89x

Quick Ratio (Quarterly)13.76x

3-Month Avg Trading Volume0.34M

52-Week Price Return-6.93%

EV / Free Cash Flow (Annual)26.73x

P/E Incl Extra (TTM)28.14x

Revenue / Employee (TTM)$406,200

Tangible BV / Share (Quarterly)$17.05

P/S Ratio (Annual)7.41x

Asset Turnover (Annual)0.41x

52-Week High$118.01

Operating Margin (5Y Avg)22.02%

EPS Excl Extra (Annual)$2.52

CapEx CAGR (5Y)17.88%

Tangible BV CAGR (5Y)25.95%

26-Week Price Return-31.15%

Quick Ratio (Annual)10.81x

13-Week Price Return-20.48%

Total Debt / Equity (Annual)0.43x

Current Ratio (Quarterly)16.31x

Enterprise Value$1.99B

Revenue / Share Growth (5Y)11.52%

Asset Turnover (TTM)0.42x

Book Value / Share Growth (5Y)15.47%

Revenue / Employee (Annual)$386,400

Inventory Turnover (Annual)1.05x

Pretax Margin (Annual)30.12%

Cash / Share (Annual)$15.77

3-Month Return Std Dev55.59%

Gross Margin (5Y Avg)67.27%

Net Income / Employee (TTM)$101,700

EBITDA CAGR (5Y)16.83%

EBITDA Interim CAGR (5Y)11.48%

ROE (Last FY)14.67%

Net Interest Coverage (Annual)18.10x

EPS Basic Excl Extra (Annual)$2.52

P/FCF (TTM)25.04x

Receivables Turnover (TTM)7.27x

EV / Free Cash Flow (TTM)26.97x

Total Debt / Equity (Quarterly)0.40x

EPS Incl Extra (TTM)$2.77

Receivables Turnover (Annual)7.84x

ROI (TTM)11.55%

Dividend Growth Rate (5Y)16.13%

P/S Ratio (TTM)7.04x

Pretax Margin (5Y Avg)23.12%

Revenue / Share (Annual)$10.89

Tangible BV / Share (Annual)$15.83

Forward P/E26.18x

Free OCF CAGR (5Y)18.54%

Price vs S&P 500 (52W)-22.46%

P/E Ratio (TTM)28.14x

EPS Growth TTM (YoY)34.39%

Year-to-Date Return-0.35%

5-Day Price Return-2.52%

EPS Normalized (Annual)$2.52

ROA (5Y Avg)8.37%

Net Profit Margin (Annual)23.13%

Month-to-Date Return-2.14%

Cash Flow / Share (TTM)$1.64

EBITD / Share (Annual)$3.21

EPS Growth (3Y)39.48%

Operating Margin (Annual)27.21%

LT Debt / Equity (Annual)0.43x

P/CF (TTM)22.27x

ROI (5Y Avg)9.47%

P/E Excl Extra (TTM)28.14x

LT Debt / Equity (Quarterly)0.40x

EPS Basic Excl Extra (TTM)$2.77

P/TBV (Quarterly)5.63x

Payout Ratio (Annual)31.37%

P/B Ratio (Annual)4.68x

Dividend / Share (TTM)$0.90

Inventory Turnover (TTM)1.02x

Pretax Margin (TTM)32.29%

Book Value / Share (Annual)$17.28

Price vs S&P 500 (13W)-23.16%

Net Margin Growth (5Y)7.15%

Dividend Yield (TTM)1.11%

Beta0.50x

P/FCF (Annual)24.82x

Revenue / Share (TTM)$10.70

ROE (TTM)16.42%

52-Week Low$78.22

vGradeC

gGradeB

mGradeC

vgmGradeC

LMAT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 4, 2026	$0.81	$0.74	-8.26%(-$0.07)
Q1 2026	May 5, 2026	$0.66	$0.68	+3.03%(+$0.02)
Q4 2025	Feb 25, 2026	$0.66	$0.68	+2.41%(+$0.02)
Q3 2025	Nov 6, 2025	$0.56	$0.75	+33.14%(+$0.19)
Q2 2025	Aug 5, 2025	$0.57	$0.60	+6.09%(+$0.03)

LMAT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About LeMaitre Vascular, Inc.

LeMaitre Vascular manufactures and distributes medical devices for treating peripheral vascular disease during open surgery, with primary revenue from lower extremity and carotid product lines. Its portfolio includes angioscopes, balloon catheters, vascular grafts, vessel closure systems, and related surgical devices. The company also processes and cryopreserves human tissues for implantation.

LMAT Next Earnings Report

Report dateNov 4, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.69

Revenue estimate$67.39M

Also reporting on Nov 4, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

AXGNAxogen, Inc. Common StockElectromedical Equipment
AEHRAehr Test SystemsInstruments for Measuring
BFLYButterfly Network, Inc.X-Ray Equipment
BLFSBioLife Solutions Inc.Electromedical Equipment
ESTAEstablishment Labs Holdings Inc.Orthopedic & Prosthetic Devices
ALMRAlamar Biosciences, Inc. Common StockLab Analytical Instruments
LUNRIntuitive Machines, Inc. Class A Common StockDefense Systems & Equipment
XRAYDENTSPLY SIRONA Inc.

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$78.22

High$118.01